<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04032457</url>
  </required_header>
  <id_info>
    <org_study_id>VS-19-01</org_study_id>
    <nct_id>NCT04032457</nct_id>
  </id_info>
  <brief_title>PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses</brief_title>
  <acronym>PAVES</acronym>
  <official_title>PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vision Service Plan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foresight Regulatory Strategies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vision Service Plan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare the short-term clinical performance and wearer and practitioner
      acceptability in a pilot study of a new-to-market spherical silicone hydrogel daily
      disposable soft contact lens (SiHyDD) to three (3) benchmark soft daily disposable lenses
      (DD) and, subsequently, of a new-to-market hydrogel spherical daily disposable (HydDD) soft
      contact lens to three (3) other hydrogel daily disposable lenses. .

      The primary outcome variables for this study are subjective comfort and lens preference.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to compare the short-term clinical performance and wearer and
      practitioner acceptability in a pilot study of a new-to-market spherical silicone hydrogel
      olifilcon B with Tangible Coating daily disposable soft contact lens (SiHyDD) to three (3)
      benchmark soft daily disposable lenses (DD) and, subsequently, of a new-to-market hydrogel
      etafilcon A with Tangible Coating spherical daily disposable (HydDD) soft contact lens to
      three (3) other hydrogel daily disposable lenses. .

      The primary outcome variables for this study are subjective comfort and lens preference.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized cross-over after 1 week of wear of two lens brands.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Clinician masking achieved by clinic coordinator dispensing lenses. Open label to participants.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Lens Preference</measure>
    <time_frame>Visit 3 - Approximately 2 weeks</time_frame>
    <description>Subjective preference for either lens intervention or no preference. Likert question with forced preference for Test or Benchmark lens or no preference.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8) score</measure>
    <time_frame>Visit 2 and 3 - Approximately 1 and 2 weeks, respectively</time_frame>
    <description>Difference in CLDEQ-8 score with treatments relative to score with habitual lenses. The scale on the 8-item CLDEQ-8 instrument is from 1 to 33, with each item having a possible 4 or 5 points.</description>
  </secondary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>A1 - SiHyDD to Moist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test SiHyDD contact lenses followed by cross over to 1 week of 1-DAY ACUVUE® Moist contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2 - Moist to SiHyDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of 1-DAY ACUVUE® Moist contact lenses followed by cross over to 1 week of Test SiHyDD contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3 - SiHyDD to OASDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test SiHyDD contact lenses followed by cross over to 1 week of ACUVUE® OASYS 1-Day contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A4 - OASDD to SiHyDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of ACUVUE® OASYS 1-Day contact lenses followed by cross over to 1 week of Test SiHyDD contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A5 - SiHyDD to DT1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test SiHyDD contact lenses followed by cross over to 1 week of Alcon DAILIES TOTAL 1® contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A6 - DT1 to SiHyDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Alcon DAILIES TOTAL 1® contact lenses followed by cross over to 1 week of Test SiHyDD contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B1 - HydDD to Moist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test HydDD contact lenses followed by cross over to 1 week of 1-DAY ACUVUE® Moist contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B2 - Moist to HydDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of 1-DAY ACUVUE® Moist contact lenses followed by cross over to 1 week of Test HydDD contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B3 - HydDD to BioTrue</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test HydDD contact lenses followed by cross over to 1 week of BIOTRUE ONEday® contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B4 - BioTrue to HydDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of BIOTRUE ONEday® contact lenses followed by cross over to 1 week of Test HydDD contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B5 - HydDD to AqCom+</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of Test HydDD contact lenses followed by cross over to 1 week of DAILIES® AquaComfort PLUS® contact lenses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B6 - AqCom+ to HydDD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 week of DAILIES® AquaComfort PLUS® contact lenses followed by cross over to 1 week of Test HydDD contact lenses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phase A - olifilcon B with Tangible Coatings</intervention_name>
    <description>Daily disposable silicone hydrogel contact lens</description>
    <arm_group_label>A1 - SiHyDD to Moist</arm_group_label>
    <arm_group_label>A2 - Moist to SiHyDD</arm_group_label>
    <arm_group_label>A3 - SiHyDD to OASDD</arm_group_label>
    <arm_group_label>A4 - OASDD to SiHyDD</arm_group_label>
    <arm_group_label>A5 - SiHyDD to DT1</arm_group_label>
    <arm_group_label>A6 - DT1 to SiHyDD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phase B - etafilcon A with Tangible Coatings</intervention_name>
    <description>Daily disposable hydrogel contact lens</description>
    <arm_group_label>B1 - HydDD to Moist</arm_group_label>
    <arm_group_label>B2 - Moist to HydDD</arm_group_label>
    <arm_group_label>B3 - HydDD to BioTrue</arm_group_label>
    <arm_group_label>B4 - BioTrue to HydDD</arm_group_label>
    <arm_group_label>B5 - HydDD to AqCom+</arm_group_label>
    <arm_group_label>B6 - AqCom+ to HydDD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy full-time wearers of spherical daily disposable contact lenses

          -  Vision correctable to 20/30 with spherical lenses in powers from +3.00 to +1.00 DS and
             from -1.00 to -7.00 DS

          -  Visual acuity corrected to at least 20/30 with spherical contact lens

        Exclusion Criteria:

          -  Participating in another clinical trial

          -  Vision not correctable to 20/30 with lens powers listed above
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robin L Chalmers, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Trial Consultant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robin L Chalmers, OD</last_name>
    <phone>678-427-6986</phone>
    <email>chalmers2097@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeff Adams</last_name>
    <phone>916-397-5231</phone>
    <email>jeff.adams@vsp.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ross Eyecare</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie M Ross, OD</last_name>
      <phone>404-233-3513</phone>
      <email>sross@rosseyecare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Professional Eye Care Center</name>
      <address>
        <city>Niles</city>
        <state>Illinois</state>
        <zip>60714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin T Kwan, OD</last_name>
      <phone>847-647-0707</phone>
      <email>Justin.t.kwan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>RevolutionEyes</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Schuetz, OD</last_name>
      <phone>317-844-2020</phone>
      <email>drschuetz@revolution-eyes.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Andover Optometry on Central</name>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Watanabe, OD</last_name>
      <phone>978-475-5252</phone>
      <email>drwatanabe@andoveroptometry.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Professional VisionCare</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William G Lay, OD</last_name>
      <phone>614-898-9989</phone>
      <email>blay@ohiovisioncare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Primary Eyecare Group, PC</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Van Hoven, OD</last_name>
      <phone>615-373-0080</phone>
      <email>PVanHoven@primaryeyecare.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 25, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact Lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

